No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals.

None of the baseline study characteristics were significantly associated with use of a risk index in bivariable analyses, although the sample size is nearly significant ( p = 0.06), with studies with larger sample sizes more likely to use a risk index when compared to studies with smaller sample sizes.

also in 3,279 other papers